NAFDAC approves Sinopharm Covid-19 vaccine for use

The National Agency for Food and Drug Administration and Control has approved the use of the Sinopharm BBIBP-CorV COVID-19 vaccine in the country.

Dr Faisal Shuaib, the Executive Director of the National Primary Health Care Development Agency announced this on Tuesday at the national vaccines briefing in Abuja.

He said that the Sinopharm vaccine was developed by Sinopharm’s Beijing Institute of Biological Products.

READ ALSO: Banks give customers ultimatum to return unutilised Forex within two weeks

The NPHCDA boss noted that the vaccine has completed three trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru and the United Arab Emirates with over 60,000 participants.

He said the BBIBP-CorV shares similar technology with CoronaVac, Covaxin, and other inactivated virus vaccines for COVID-19.

Dr Faisal also said that NAFDAC recently gave the nod for its use in Nigeria although the vaccine had received the World Health Organisation certification.

“NAFDAC has approved the Sinopharm vaccine, the approval was given three days ago; and yes, the Sinopharm vaccine has also received WHO certification,” he said.